Gosset Ownership
Private
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Nivagen Pharmaceuticals General Information
Nivagen has a commercial portfolio of more than 18 drugs marketed in the US. The company focuses on developing complex generics and value-added specialty pharmaceuticals. It has an active pipeline that includes both internal development programs and co-development partnerships. Recent clinical results or trial data are not publicly detailed for individual programs.
Contact Information
Website
Primary Industry
Biotech
Corporate Office
Sacramento, California
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Co-development partners with disruptive technologies, Global partnerships with FDA-approved manufacturing facilities
Nivagen Pharmaceuticals Funding
No funding data available
To view Nivagen Pharmaceuticals's complete valuation and funding history, request access »